1. A humanized neutralizing antibody protects against human adenovirus type 7 infection in humanized desmoglein-2 and CD46 double-receptor transgenic mice
- Author
-
Chengxing Zhou, Xiaohong Liao, Zhichao Zhou, Chuncong Mo, Yujie Yang, Hui Liao, Minglei Liu, Qiong Zhang, Qiuru Li, Xingui Tian, Rong Zhou, and Hong Cao
- Subjects
Human adenovirus type 7 ,Neutralizing monoclonal antibodies ,Receptors ,Transgenic mice ,Humanized antibodies ,Infectious and parasitic diseases ,RC109-216 - Abstract
Abstract Background Human adenovirus type 7 (HAdV7) has become a major public health threat due to its widespread transmission, severe associated pneumonia, and a lack of effective anti-HAdV7 drugs. The aim of the current study is to design a humanized monoclonal antibody (mAb) demonstrating efficacy against HAdV-7 infections in vitro and in vivo. Methods The humanized neutralizing antibody, 3G5-hu, was derived from the murine mAb 3G5. Antibody activity was evaluated using a flow cytometry-based neutralization (FCN) assay to identify humanized mAbs retaining potent neutralizing activity. Additionally, a humanized hDSG2/hCD46 dual-receptor transgenic mouse model was developed to simulate HAdV-7 infection. Results Using recombinant HAdV-7 expressing enhanced green fluorescent protein and clinically isolated wild-type HAdV-7, the half-maximal effective concentration of 3G5-hu against HAdV-7 was determined to be
- Published
- 2024
- Full Text
- View/download PDF